Loading...
XNAS
SILK
Market cap1.12bUSD
Sep 16, Last price  
27.49USD
Name

Silk Road Medical Inc

Chart & Performance

D1W1MN
XNAS:SILK chart
P/E
P/S
6.31
EPS
Div Yield, %
Shrs. gr., 5y
6.21%
Rev. gr., 5y
38.66%
Revenues
177m
+27.77%
14,258,00034,557,00063,354,00075,227,000101,475,000138,638,000177,134,000
Net income
-56m
L-3.92%
-19,356,000-37,629,000-56,073,000-50,385,000-50,387,000-58,016,000-55,743,000
CFO
-32m
L-1.74%
-25,252,000-21,695,000-29,610,000-42,068,000-38,935,000-32,581,000-32,014,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Silk Road Medical, Inc. operates as a medical device company in the United States. The company offers various products for the treatment of carotid artery disease called transcarotid artery revascularization. Its products include ENROUTE Transcarotid Neuroprotection System that is used to directly access the common carotid artery and initiate temporary blood flow reversal; ENROUTE Transcarotid Stent System, a self-expanding, self-tapering stent; ENHANCE Transcarotid Peripheral Access Kit for use in gaining initial access to the common carotid artery; and ENROUTE 0.014 Guidewire for navigating and crossing the target lesion for delivery of interventional devices. The company was incorporated in 2007 and is headquartered in Sunnyvale, California.
IPO date
Apr 04, 2019
Employees
414
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT